4 ms·
Exactly. And the dosage being given for COVID-19 patients is comparable to the dosage given for patients with chronic conditions such as lupus, only the COVID-1
by mariodiana 6y ago
Exactly. And the dosage being given for COVID-19 patients is comparable to the dosage given for patients with chronic conditions such as lupus, only the COVID-19 patients are given the drug for something like a week, while the chronic patients are given the drug indefinitely.
Meanwhile, drugs like benzodiazepines are basically just dumped on a largely unwitting populace with the tacit blessing of these very same people who are fretting about hydroxychloroquine. There is more than simply the disinterested caution of science going on here.
- lbeltrame 6y agoTo be honest, dosage varies a lot across countries. The trials in Brazil gave very high dosage, which can probably explain the deaths from cardiotoxicity there.
- core-questions 6y agoShh, don't mention the opiate / benzo crisis. We know this disproportionately affects Middle America, and therefore is not something we can bring up as a serious topic of conversation.